Hisamitsu Pharmaceutical Co Inc (JP:4530)
:4530
Want to see JP:4530 full AI Analyst Report?
Total Valuation
Hisamitsu Pharmaceutical Co has a market cap or net worth of ¥440.91B. The enterprise value is ¥319.02B.
Market Cap¥440.91B
Enterprise Value¥319.02B
Share Statistics
Hisamitsu Pharmaceutical Co has 75,164,894 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding75,164,894
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Hisamitsu Pharmaceutical Co’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 4.66%.
Return on Equity (ROE)0.07
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)4.66%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee59.09M
Profits Per Employee6.94M
Employee Count2,759
Asset Turnover0.44
Inventory Turnover2.58
Valuation Ratios
The current PE Ratio of Hisamitsu Pharmaceutical Co is 22.5. Hisamitsu Pharmaceutical Co’s PEG ratio is -2.46.
PE Ratio22.5
PS Ratio2.64
PB Ratio1.47
Price to Fair Value1.47
Price to FCF45.37
Price to Operating Cash Flow0.00
PEG Ratio-2.46
Income Statement
In the last 12 months, Hisamitsu Pharmaceutical Co had revenue of 163.02B and earned 19.16B in profits. Earnings per share was 268.55.
Revenue163.02B
Gross Profit96.12B
Operating Income17.92B
Pretax Income23.66B
Net Income19.16B
EBITDA24.97B
Earnings Per Share (EPS)268.55
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Hisamitsu Pharmaceutical Co pays an annual dividend of ¥60, resulting in a dividend yield of 2.43%
Dividend Per Share¥60
Dividend Yield2.43%
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.33
52-Week Price Change35.47%
50-Day Moving Average6.10K
200-Day Moving Average4.85K
Relative Strength Index (RSI)49.22
Average Volume (3m)139.59K
Important Dates
Hisamitsu Pharmaceutical Co upcoming earnings date is Jul 9, 2026, TBA (Confirmed).
Last Earnings DateApr 13, 2026
Next Earnings DateJul 9, 2026
Ex-Dividend Date―
Financial Position
Hisamitsu Pharmaceutical Co as a current ratio of 4.08, with Debt / Equity ratio of 0.81%
Current Ratio4.08
Quick Ratio3.57
Debt to Market Cap<0.01
Net Debt to EBITDA-4.26
Interest Coverage Ratio853.24
Taxes
In the past 12 months, Hisamitsu Pharmaceutical Co has paid 4.10B in taxes.
Income Tax4.10B
Effective Tax Rate0.17
Enterprise Valuation
Hisamitsu Pharmaceutical Co EV to EBITDA ratio is 12.97, with an EV/FCF ratio of 34.14.
EV to Sales1.99
EV to EBITDA12.97
EV to Free Cash Flow34.14
EV to Operating Cash Flow18.52
Balance Sheet
Hisamitsu Pharmaceutical Co has ¥118.13B in cash and marketable securities with ¥2.65B in debt, giving a net cash position of ¥115.48B billion.
Cash & Marketable Securities¥118.13B
Total Debt¥2.65B
Net Cash¥115.48B
Net Cash Per Share¥1.54K
Tangible Book Value Per Share¥4.06K
Margins
Gross margin is 58.96%, with operating margin of 10.99%, and net profit margin of 11.75%.
Gross Margin58.96%
Operating Margin10.99%
Pretax Margin14.51%
Net Profit Margin11.75%
EBITDA Margin15.32%
EBIT Margin10.99%
Analyst Forecast
The average price target for Hisamitsu Pharmaceutical Co is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast3.53%
EPS Growth Forecast38.23%